Treace Medical Concepts (TMCI) Depreciation & Amortization (CF) (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $899000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 63.47% year-over-year to $899000.0; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (up 1.0% YoY), and the FY2025 full-year result was $10.6 million, up 26.18% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $899000.0, down from $2.8 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $2.8 million in Q4 2025 and bottomed at $300000.0 in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.8 million (2023), against an average of $1.6 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) jumped 300.0%; it then slumped 63.47% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $917000.0 in 2022, then soared by 92.91% to $1.8 million in 2023, then gained by 26.46% to $2.2 million in 2024, then gained by 25.53% to $2.8 million in 2025, then slumped by 67.98% to $899000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $899000.0 (Q1 2026), $2.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison